“…After pioneering applications of SERS NPs for molecular imaging were introduced in vivo by Gambhir’s group, , several research teams focused their efforts toward (1) developing new Raman imaging tools; (2) unraveling the multiplexing potential of SERS NPs; ,− (3) increasing their sensitivity down to sub-fM limits of detection (LODs); (4) increasing penetration depth of Raman imaging; − (5) improving speed of Raman imaging in conjunction with SERS NPs; (6) optimizing spectral unmixing algorithms; and (7) adding multiple imaging modalities. − Furthermore, SERS NPs have demonstrated their potential in detection of various important biomarkers such as carbonic anhydrase IX (CA9), cluster of differentiation 24 (CD24), CD44, , CD47, ,, epidermal growth factor receptor (EGFR), − ,,− epithelial cellular adhesion molecule (EpCAM), estrogen receptor (ER), human epididymis protein 4 (HE4), human epidermal growth factor receptor 2 (HER2), − ,, programmed death-ligand 1 (PD-L1), , and progesterone receptor (PR) . However, most studies have not comprehensively analyzed the distinctive attributes of the SERS NPs for achieving a high biotargeting specificity.…”